P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM START OF ENROLLMENT

• Wojciech Jurczak,
• Pier Luigi Zinzani,
• Toby A. Eyre,
• Chan Y. Cheah,
• Chaitra S. Ujjani,
• Koji Izutsu,
• Shuo MA,
• Ian Flinn,
• Alvaro J. Alencar,
• David Lewis,
• Krish Patel,
• Kami Maddocks,
• Yucai Wang,
• Talha Munir,
• Andrew D. Zelenetz,
• Minna Balbas,
• Donald E. Tsai,
• Chunxiao Wang,
• Michael L. Wang,
• Nirav N. Shah

Affiliations

Wojciech Jurczak

1 Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland

Pier Luigi Zinzani

2 IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy

Toby A. Eyre

4 Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom

Chan Y. Cheah

5 Medical School, University of Western Australia, Perth, Australia

Chaitra S. Ujjani

7 Fred Hutchinson Cancer Research Center, University of Washington, Washington, United States

Koji Izutsu

8 National Cancer Center Hospital, Department of Hematology, Tokyo, Japan

Shuo MA

9 Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, United States

Ian Flinn

10 Sarah Cannon Research Institute and Tennessee Oncology, Nashville, United States

Alvaro J. Alencar

11 Sylvester Comprehensive Cancer Center, Miami, United States

David Lewis

12 Plymouth Hospitals NHS Trust - Derriford Hospital, Plymouth, United Kingdom

Krish Patel

13 Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, United States

Kami Maddocks

14 The Ohio State University Comprehensive Cancer Center, Columbus, United States

Yucai Wang

15 Mayo Clinic, Division of Hematology, Rochester, United States

Talha Munir

16 St. James’s University Hospital, Department of Haematology, Leeds, United Kingdom

Andrew D. Zelenetz

17 Memorial Sloan Kettering Cancer Center, New York, United States

Minna Balbas

18 Loxo@Lilly, Indianapolis, United States

Donald E. Tsai

18 Loxo@Lilly, Indianapolis, United States

Chunxiao Wang

19 Eli Lilly and Company, Indianapolis, United States

Michael L. Wang

20 MD Anderson Cancer Center, Houston, United States

Nirav N. Shah

21 Medical College of Wisconsin, Milwaukee, United States